Skip to main content
Fig. 13 | Biomaterials Research

Fig. 13

From: Recent trends in therapeutic application of engineered blood purification materials for kidney disease

Fig. 13

a–c SEM and energy dispersive X-ray spectroscopy (EDX) mapping images of beta-type 940-HOA zeolite (10 wt%)–EVOH nanofiber composite produced from 7 w/v% HFIP (scale bar: 8 μm). d Nanofiber is composed of blood compatible poly (ethylene-co-vinyl alcohol) as the primary matrix polymer and zeolites that are capable of selectively adsorbing uremic toxins. e, f Creatinine adsorption capacity of 940-HOA zeolite nanofibers by fiber mass (e) and zeolite mass (f) in the absence (open bar) or presence (closed bar) of flow. Reproduced with permission [36]. Copyright 2013, Royal Society of Chemistry

Back to article page

Biomaterials Research

ISSN: 2055-7124

Contact us